tiprankstipranks
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
Company AnnouncementsHansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
10d ago
3692
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
PremiumCompany Announcements
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
10d ago
3692
Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
PremiumCompany Announcements
Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
11d ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
16d ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
16d ago
3692
Hansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend
PremiumCompany AnnouncementsHansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend
21d ago
3692
Hansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
Premium
Company Announcements
Hansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
1M ago
3692
Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
Premium
Company Announcements
Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
2M ago
3692
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
PremiumCompany Announcements
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
2M ago
3692
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
PremiumCompany Announcements
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
2M ago
3692
Hansoh Pharma Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
PremiumCompany Announcements
Hansoh Pharma Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
3M ago
3692
Hansoh Pharma Licenses Hengrui’s Late-Stage Kidney Drug SHR6508 for China
PremiumCompany Announcements
Hansoh Pharma Licenses Hengrui’s Late-Stage Kidney Drug SHR6508 for China
3M ago
3692
Hansoh Pharma Adds Veteran Lawyer Yan Jia to Board, Bolsters Governance Committees
PremiumCompany AnnouncementsHansoh Pharma Adds Veteran Lawyer Yan Jia to Board, Bolsters Governance Committees
3M ago
3692
Hansoh Pharmaceutical Details Board Composition and Committee Roles
Premium
Company Announcements
Hansoh Pharmaceutical Details Board Composition and Committee Roles
3M ago
3692
Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib
Premium
Company Announcements
Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib
4M ago
3692
Hansoh Pharmaceutical Advances with New Drug Inclusions in 2025 NRDL
PremiumCompany Announcements
Hansoh Pharmaceutical Advances with New Drug Inclusions in 2025 NRDL
4M ago
3692
Hansoh Pharmaceutical’s New Drug Application for Lung Cancer Treatment Accepted
PremiumCompany Announcements
Hansoh Pharmaceutical’s New Drug Application for Lung Cancer Treatment Accepted
6M ago
3692
Hansoh Pharmaceutical Partners with Roche for Global Cancer Drug Development
PremiumCompany Announcements
Hansoh Pharmaceutical Partners with Roche for Global Cancer Drug Development
6M ago
3692
Hansoh Pharmaceutical Announces Interim Dividend for 2025
PremiumCompany Announcements
Hansoh Pharmaceutical Announces Interim Dividend for 2025
7M ago
3692
Hansoh Pharmaceutical Adjusts Interim Dividend Dates Due to Weather
PremiumCompany AnnouncementsHansoh Pharmaceutical Adjusts Interim Dividend Dates Due to Weather
7M ago
3692
Hansoh Pharmaceutical’s XINYUE Gains Second Indication Approval in China
Premium
Company Announcements
Hansoh Pharmaceutical’s XINYUE Gains Second Indication Approval in China
7M ago
3692
Hansoh Pharmaceutical Announces New Share Placement to Raise HK$3.9 Billion
Premium
Company Announcements
Hansoh Pharmaceutical Announces New Share Placement to Raise HK$3.9 Billion
8M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >